Artificial intelligence (AI) is no longer limited to tech labs. OpenAI launched ChaGPT in 2022. Since then AI chatbots have ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...